
Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.
Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.
In more severe cases, the infection can lead to breathing difficulties, especially for elderly individuals and those with pre-existing lung…
For the nine-month period ending September 2024, Checkpoint reported $0.04 million in revenue and a net loss of $27.3 million.
Adults ages 18 to 60 need at least seven hours of sleep per night, according to the Centers for Disease…
Martin Holst Lange, Executive Vice President, Development, Novo Nordisk, highlighted during the press briefing that their purpose is to address…
Trump’s tariff threat: Experts have warned that additional levies will only serve to push up prices in the already costly…
The 2025 funding cuts will have a devastating impact on TB programmes, particularly in LMICs that rely heavily on international…
According to a statement by the European Society of Cardiology, the most common heart rhythm disorder, atrial fibrillation, has seen…
Loneliness has been found to heighten the risk of heart disease, depression, and weakened immunity.
As of 2024, India has emerged as the world’s largest supplier of generic medicines, with a 9% pharma export growth…
Patients are experiencing extended recovery periods, with symptoms lasting up to 10 days, longer than the typical 5-7 days.
Breast Cancer cases surge: The report also showed that based on 2022 rates, globally 1 in 20 women will be…
The Ministry also revealed that a joint team from the CDSCO and the State Regulatory Authority conducted a comprehensive audit…
Gut health is about how well your body digests food, absorbs nutrients, and maintains a balance of good and bad…
Indian drugmakers earn a significant share of revenue from the United States, the largest importer of Indian pharma products.
GBS outbreak: In Karnataka the state health department is ramping up (GBS) disease surveillance and monitoring efforts to prevent a…
To date, the FDA has approved 65 biosimilar products for a variety of health conditions.
Dr Shreya Dubey – Consultant – Neonatology & Paediatrics, CK Birla Hospital Gurgaon revealed that children are highly vulnerable to…